Geode Capital Management
GLSI icon

Geode Capital Management’s Greenwich LifeSciences GLSI Stock Holding History

Geode Capital Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Buy
168,179
+12,713
+8% +$309K ﹤0.01% 3016
2026
Q1 		$3.74M Buy
155,466
+3,782
+2% +$98.6K ﹤0.01% 2884
2025
Q4 		$3.19M Buy
151,684
+9,568
+7% +$101K ﹤0.01% 2980
2025
Q3 		$1.41M Buy
142,116
+3,134
+2% +$35.4K ﹤0.01% 3295
2025
Q2 		$1.26M Buy
138,982
+1,972
+1% +$18.8K ﹤0.01% 3262
2025
Q1 		$1.31M Buy
137,010
+2,939
+2% +$35.6K ﹤0.01% 3210
2024
Q4 		$1.51M Buy
134,071
+521
+0.4% +$6.97K ﹤0.01% 3226
2024
Q3 		$1.92M Buy
133,550
+5,861
+5% +$86.8K ﹤0.01% 3143
2024
Q2 		$2.2M Buy
127,689
+69,445
+119% +$1.01M ﹤0.01% 3102
2024
Q1 		$1.16M Buy
58,244
+11,428
+24% +$141K ﹤0.01% 3312
2023
Q4 		$493K Buy
46,816
+724
+2% +$7.26K ﹤0.01% 3617
2023
Q3 		$408K Buy
46,092
+6,159
+15% +$57.8K ﹤0.01% 3679
2023
Q2 		$385K Hold
39,933
– – ﹤0.01% 3746
2023
Q1 		$551K Hold
39,933
– – ﹤0.01% 3608
2022
Q4 		$606K Sell
39,933
-2,326
-6% -$26.6K ﹤0.01% 3576
2022
Q3 		$384K Buy
42,259
+1,280
+3% +$11.8K ﹤0.01% 3869
2022
Q2 		$347K Sell
40,979
-28,733
-41% -$329K ﹤0.01% 3958
2022
Q1 		$1.37M Buy
69,712
+2,292
+3% +$46.3K ﹤0.01% 3465
2021
Q4 		$1.64M Buy
67,420
+10,501
+18% +$351K ﹤0.01% 3474
2021
Q3 		$2.22M Buy
56,919
+4,524
+9% +$189K ﹤0.01% 3298
2021
Q2 		$2.35M Buy
52,395
+37,932
+262% +$1.43M ﹤0.01% 3215
2021
Q1 		$493K Buy
14,463
+7,443
+106% +$253K ﹤0.01% 3815
2020
Q4 		$256K Buy
+7,020
New +$102K ﹤0.01% 3810

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Geode Capital Management's GLSI Position: Q2 2026 in Review

Geode Capital Management increased its Greenwich LifeSciences (GLSI) stake by 8.2% in Q2 2026, buying an estimated $309K and bringing the position to 168,179 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Geode Capital Management first reported a position in GLSI in Q4 2020 and has held it in 23 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Geode Capital Management held 168,179 shares of Greenwich LifeSciences worth $3.95M as of Q2 2026.
  • Geode Capital Management bought 12,713 Greenwich LifeSciences shares in Q2 2026, an estimated $309K.
  • Greenwich LifeSciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3016 holding.
  • Geode Capital Management first reported a position in Greenwich LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.